Cargando…

Ascorbic acid: a promising agent in chronic kidney disease?

Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problem in CKD patients, and both have an impo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karahan, Salih, Afsar, Baris, Kanbay, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Cardiovascular Disease in CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070088/ https://www.ncbi.nlm.nih.gov/pubmed/30094017 http://dx.doi.org/10.1093/ckj/sfy044

Ejemplares similares

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
por: Gillis, Keith, et al.
Publicado: (2018)

Capillary rarefaction from the kidney point of view
por: Afsar, Baris, et al.
Publicado: (2018)

Epidemiology of chronic kidney disease: think (at least) twice!
por: Delanaye, Pierre, et al.
Publicado: (2017)

The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
por: Lepeytre, Fanny, et al.
Publicado: (2017)

Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa
por: Adeniyi, Aderemi B., et al.
Publicado: (2017)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system
por: Strait, Adrienne, et al.
Publicado: (2018)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

Approach to atherosclerotic renovascular disease: 2016
por: Daloul, Reem, et al.
Publicado: (2016)

Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016)

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
por: Golbin, Léonard, et al.
Publicado: (2017)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Medication discrepancies in late-stage chronic kidney disease
por: Ibrahim, Jamil, et al.
Publicado: (2018)

2017 update on pain management in patients with chronic kidney disease
por: Pham, Phuong Chi, et al.
Publicado: (2017)

Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease
por: O’Sullivan, Tom F, et al.
Publicado: (2018)

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
por: Mechta Nielsen, Trine, et al.
Publicado: (2018)

Chronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exercise
por: Gollie, Jared M, et al.
Publicado: (2018)

Elderly patients with chronic kidney disease: do they really need referral to the nephrology clinic?
por: McClure, Mark, et al.
Publicado: (2017)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019)

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018)

Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?
por: Cianciolo, Giuseppe, et al.
Publicado: (2017)

Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2018)

Impact of a phone app on nephrology referral
por: Oliva-Damaso, Nestor, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g5nvdgohn0fvvn3gom3eqqs9oj